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Straining to Justify Strain Measurement*
Orlando P. Simonetti, PHD, Subha V. Raman, MD
Columbus, OhioWhen thus the heart is in a vein
Of tender thought, the simplest strain
Can touch it with peculiar power.
—Sir Thomas Moore (1)
A broad array of cardiac imaging research and
technique development has been deployed in the
quest to define the earliest myocardial changes of
cardiomyopathy so that earlier detection may afford
more timely institution of therapy and improved
outcomes. Recognition that high-resolution mea-
sures of myocardial deformation can be abnormal
before global contractile dysfunction has further
fueled development of techniques such as speckle
tracking, myocardial tagging, displacement-encoded
See page 144
imaging, and vector velocity imaging. Nonetheless,
one must strain to find clinicians who rely on any of
these techniques for routine management decisions
despite more than 20 years of technical refinement
since the first myocardial tagging methods were
described by Zerhouni et al. (2) and Axel and
Dougherty (3). Rather, these approaches remain on
the fringe of care, limited to the realm of interesting
techniques seeking clinical relevance.
In an era when imaging lies squarely in the cross-
hairs of cost containment and health care reform, the
reasons for this failure of strain measurement to gain
any meaningful clinical use must be examined. Is it
inconsistency in data acquisition? Does the burden of
time-consuming post-processing limit practical appli-
cability? Have we not met the threshold of evidence
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support from Siemens.required to demonstrate that detection of subclinical
strain abnormalities leads to tangible improvements in
outcomes? Or does contemporary heart failure prac-
tice cling too fervently to traditional hemodynamic,
structural, and functional measures to incorporate new
approaches? In light of more than 5.7 million Amer-
icans with heart failure who face a 20% 1-year mor-
tality rate, improvements in methods of early diagno-
sis and treatment are clearly still needed.
In this issue of iJACC, Hor et al. (4) present a
new technique for measuring peak systolic circum-
ferential strain (cc) from routinely acquired cardiac
magnetic resonance (CMR) cine images. The ap-
plication of feature-tracking algorithms, designed
originally for echocardiographic image analysis, to
CMR cine images is a novel approach with poten-
tial advantages over existing methods. Such a tech-
nique would eliminate the need for additional
time-consuming scans designed specifically for
strain measurement such as tagging, displacement
encoding, and phase-velocity imaging. Addition-
ally, the described method of CMR feature tracking
is rapid and automated. Their technique showed
good agreement with strain measurement using
tagged cine, a separate acquisition technique not
routinely performed but historically the standard for
CMR-based strain analysis that has been validated
against sonomicrometry. Reproducibility among
observers was also good, although data on the same
observers’ analyses of tagged cine data would have
been useful for comparison. When applied to cine
images from healthy controls and patients with
Duchenne muscular dystrophy (DMD), the result-
ing strain measurements discriminated among
groups with progressive myocardial disease. A most
useful finding was that feature tracking–derived cc
in DMD patients showed abnormalities even in the
setting of preserved systolic function, offering hope
for earlier detection of inevitable cardiomyopathy in
these patients.
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153Although the authors claim that circumferential,
ongitudinal, and radial tissue velocity; displace-
ent; strain; and strain rate could all be computed
y feature tracking, only cc averaged over a single
idventricular slice was reported. The accuracy and
eliability of regional measures of strain in multiple
irections, and their applicability to diastolic strain
easurement, remain unknown. The mix of acqui-
ition techniques, including 3-T versus 1.5-T and
reath-holding versus free-breathing, leaves some
ncertainty as to applicability for a given acquisition
ode. Covariate analysis by field strength and cine
equence would help address this before clinical
mplementation.
The endocardial feature tracking approach was
ot without limitations. Tagging-based cc mea-
urement discriminated between younger and older
MD patients, yet feature tracking–based cc
ould not detect this difference. One would expect
he difference to be real as DMD-associated car-
iomyopathy advances with age. There was also a
light underestimation of cc by feature tracking
ersus tagged cine analysis, and the difference be-
ween techniques increased as one progressed
hrough patient groups with more advanced cardio-
yopathy. This divergence warrants further inves-
igation, even if the greatest utility for strain mea-
urement in this population may be in earlier
etection when left ventricular ejection fraction is
ormal.
A potential explanation for reduced sensitivity
nd slightly lower strain values is that the feature
racking algorithm tracks the deformation of only
he endocardial border, not the epicardium, poten-
ially losing transmural information captured in tag
Figure 1. Late Post-Gadolinium Imaging of Dystrophin-Associat
The typical late gadolinium enhancement pattern seen in dystrophi
similar to myocarditis. Applying thresholding to display pixels with
is shown (right). LV  left ventricle; RV  right ventricle.rids that span the entire thickness of the ventric-
lar wall. Mechanistically, this fits with the pathol-
gy of DMD-associated cardiomyopathy, which is
haracterized by epicardial injury by ex vivo histo-
athology and demonstrable in vivo with late post-
adolinium imaging (Fig. 1).
Abnormal strain has been shown to precede
ystolic dysfunction in pre-clinical models of
MD-associated cardiomyopathy (5). Although
iastolic strain data were not presented in this work,
ne could envision that the proposed feature-
racking approach would offer a more robust calcu-
ation of diastolic strain using standard cine data
ersus techniques such as tagging and displacement
ncoding, which may not be capable of measuring
train across the entire cardiac cycle due to T1
elaxation. However, the authors do point out that
his is less problematic at 3-T due to the inherently
onger tissue T1 values.
Assuming that we now have a technique for
outine, reproducible, and relatively painless myo-
ardial strain measurement, what further evidence is
eeded to justify clinical use? Software advances
hat provide features such as visually appealing
train maps in place of manual comparison of
egmental strain data would be a welcome and
ritical step before there can be wider adoption of
train measurement. Clinical trials have already
hown that, using global left ventricular ejection frac-
ion by echocardiography to guide initiation of ther-
py, treatment of DMD patients with angiotensin-
onverting enzyme inhibitors limits initiation and
rogression of cardiomyopathy (6). Prospective
tudies randomizing patients to therapeutic deci-
ion making with or without strain measurement
ardiomyopathy
sociated cardiomyopathy (left) involves the lateral epicardium,
al intensity 2 SDs above the mean of nonenhancing myocardiumed C
n-as
sign
m
t
m
e
t
s
a
c
t
v
a
i
p
c
t
i
f
a
a
c
t
R
T
R
1
2
3
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 3 , N O . 2 , 2 0 1 0
F E B R U A R Y 2 0 1 0 : 1 5 2 – 4
Simonetti and Raman
Editorial Comment
154ay be required (7). Extension of studies such as
his to include patient outcomes and appropriate
ultivariate analysis to demonstrate the cost-
ffectiveness and added value of strain measurement
o existing clinical, structural, and functional mea-
urements will also be essential. The high morbidity
nd mortality in patients with heart failure give
linicians little time for techniques that reveal sub-
leties without proven impact on outcomes. Con-
ersely, those that afford more accurate diagnosis
nd precision in assigning prognosis hold the prom-
se of earlier institution of appropriate treatment to841–5. function in Duchenarticularly true in the management of patients with
ardiomyopathies, in which early institution of
herapies such as angiotensin-converting enzyme
nhibitors and beta-blockers before end-stage heart
ailure has set in has repeatedly proven beneficial
cross the etiologic spectrum. This work has made
small but important step forward in realizing a
linical role for myocardial strain measurement in
he evaluation of cardiomyopathy.
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